See also
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Abbott Laboratories, Common-Size Consolidated Income Statement
| Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | Dec 31, 2006 | ||
|---|---|---|---|---|---|---|
 |
Net sales | |
|
|
|
|
|
Cost of products sold | |
|
|
|
|
|
Gross profit | % |
% |
% |
% |
% |
|
Research and development | |
|
|
|
|
|
Acquired in-process research and development | |
|
|
|
|
|
Selling, general and administrative | |
|
|
|
|
|
Operating earnings | % |
% |
% |
% |
% |
|
Interest expense | |
|
|
|
|
|
Interest income | |
|
|
|
|
|
Income from the TAP Pharmaceutical Products Inc. joint venture | |
|
|
|
|
|
Net foreign exchange gain (loss) | |
|
|
|
|
|
Other income (expense), net | |
|
|
|
|
|
Earnings from continuing operations before taxes | % |
% |
% |
% |
% |
|
Taxes on earnings from continuing operations | |
|
|
|
|
|
Earnings from continuing operations | % |
% |
% |
% |
% |
|
Gain on sale of discontinued operations, net of taxes | |
|
|
|
|
|
Net earnings | % |
% |
% |
% |
% |
February 8, 2012